Elidel-Study: Elidel in Patients With Atopic Dermatitis

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Atopic dermatitis is a common disease. Emollients and Elidel have both shown to be effective to treat this disease. The research question is, whether the effective component (Elidel) is better than the emollient to improve the skin function.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Technische Universität Dresden
• Treatments: Pimecrolimus

Criteria

Inclusion Criteria:

• Age > 18 years

• Atopic dermatitis on both lower arms at least 1% body surface area.

• Atopic Dermatitis Severity Index (ADSI)-Score >= 6

• Investigator Global Assessment (IGA)-Score >= 2

Exclusion Criteria:

• Systemic therapy with immunosuppressive drugs within the past 24 weeks

• Phototherapy against atopic dermatitis.

• Antibiotic therapy against atopic dermatitis.

• Allergy against Elidel.

• Pregnancy

• Nursing

• Skin cancer